Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will set a target time for women to receive treatment from specialist referred services after they first present symptoms of heavy menstrual bleeding in primary care.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We recognise the severe impact that heavy menstrual bleeding can have on women and girls, which is why improving care for menstrual problems, including heavy menstrual bleeding, is among our 2024 priorities for the Women’s Health Strategy.
Many women can have heavy menstrual bleeding managed in a general practice and women’s health hubs. We are investing £25 million in women’s health hubs, so that women can get better access to care for essential services in the community. One of the core services of women’s health hubs is menstrual problems assessment and treatment, including for women experiencing heavy menstrual bleeding.
Accessing treatment at a health hub can avoid the need for a referral to secondary care, and therefore cut waiting times, one of the Prime Minister’s top priorities. We are making good progress on tackling the longest waits, to ensure patients get the care they need when they need it. The main standard in elective performance is the referral-to-treatment standard. The NHS Constitution sets out that a minimum of 92% of patients waiting for their first definitive elective treatment, including patients with heavy menstrual bleeding, should have been waiting no more than 18 weeks from referral.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of including a screening process for heavy menstrual bleeding for women attending primary care surgeries for gynecological (a) procedures and (b) consultations.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
No formal assessment has been made. Improving care for menstrual problems, including heavy menstrual bleeding, is among our 2024 priorities for the Women’s Health Strategy. We recognise the severe impact that heavy menstrual bleeding can have on women, and we are taking steps to improve access to care so that women experiencing heavy menstrual bleeding can receive the care they need. We are investing £25 million in women’s health hubs, so that women can get better access to care for essential services, including for menstrual problems such as heavy menstrual bleeding.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if her Department will take steps to categorise heavy menstrual bleeding as a chronic disabling condition.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We do not currently have any plans to categorise heavy menstrual bleeding as a chronic disabling condition. Improving care for menstrual problems, including heavy menstrual bleeding, is among our 2024 priorities for the Women’s Health Strategy. We recognise the severe impact that heavy menstrual bleeding can have on women throughout much of their lives, and we are taking steps to improve access to care, so that women experiencing heavy menstrual bleeding can be treated. We are investing £25 million in women’s health hubs, so that women can get better access to care for essential services, including for menstrual problems such as heavy menstrual bleeding.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with a brain tumour through the non-specific symptoms pathway.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The latest data shows that fewer than 10 brain and central nervous system (CNS) cancers have been diagnosed through non-specific symptom (NSS) pathways, or 0.4% of all cancers diagnosed through NSS pathways. Brain and CNS cancers are not one of the most common types diagnosed through NSS pathways.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions she has had with trade unions representing Agenda for Change staff.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
My Rt hon. Friend, the Secretary of State for Health and Social Care has had a number of recent meetings with representatives of the Agenda for Change trade unions, to hear their individual and collective priorities for pay, and terms and conditions.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, for what reason is the shingles vaccine not available to people between the ages of 66 to 69 on 1 September 2023; and whether she will make an assessment of the potential impact of not providing the vaccine on those people.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The current policy offers the shingles vaccine shingrix to anyone who turned 65 or 70 years old on or after 1 September 2023, and to anyone aged 50 years old and over, who is at higher risk of serious complications as a result of having a severely weakened immune system. This approach has been used in the effective implementation of previous immunisation programmes. Whilst some individuals may have to wait until they are eligible, the population benefit of adopting this approach is greater, and means that many individuals will receive the vaccine sooner and will benefit for longer.
The approach is modelled on the first shingles programme, optimising achievements within the resources and capacity of the National Health Service, while being delivered alongside other important healthcare priorities, and avoiding undue additional pressure on NHS delivery services. An assessment of the potential impact of not providing the vaccine to people aged 66 to 69 years old is not required, as they remain eligible to receive a shingles vaccination when they turn 70 years old, as they would have done prior to 1 September 2023.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, for what reason the compensation scheme for people suffering from the effects of vaginal mesh operations does not cover all those impacted by the use of the same materials in rectopexy procedures.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh.
While the PSC does not include rectopexy mesh within her proposed definition of directly harmed patients for the purposes of her redress recommendations, we note that the PSC has said in her report that the Government needs to consider how to investigate issues related to harm caused by other uses of mesh going forward. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will (a) list the amount of funding allocated to each children's hospice for the 2024-25 financial year and (b) outline her Department's timescale for distributing this funding to each hospice.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Last year, NHS England confirmed that it will be renewing the funding for Children and Young People’s hospices for 2024/25, once again allocating £25 million of funding, using the same prevalence-based allocation approach as in 2022/23 and 2023/24. This prevalence-based approach ensures that the funding matches local need.
The distribution of the 2024/25 funding to children’s hospices will be via integrated care boards (ICBs), in line with the wider move to a devolved National Health Service, in which ICBs are best placed to meet the health and care needs of their local population. The Department and NHS England hope to be able to provide the greater clarity that the sector is seeking on this important funding stream shortly.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the Warwickshire, Solihull and Coventry Breast Screening Unit is taking as part of the breast screening improvement plan; what the timeline is for their delivery; and how much funding has been allocated for their delivery.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England Midlands is the responsible commissioner for the NHS Breast Cancer Screening Programme delivered across the Warwickshire, Solihull, and Coventry locality. The Warwickshire, Solihull, and Coventry service is one of the largest breast screening services in England, inviting approximately 55,000 people for screening each year.
NHS England Midlands has advised that for the breast screening improvement plan, work has begun on reviewing coverage for the Warwickshire, Solihull, and Coventry breast screening services. The service continues to collaborate with primary care practices to promote uptake for patients in low uptake areas, and staff facilitate local community events to educate on the importance of breast screening, for instance at the Godiva and Pride Festivals in Coventry.
In 2024/25 the service will receive a contract value in excess of £3 million, to ensure that cancer is detected early through screening. The service has also received capital investment during the last two years, which has supported additional imaging equipment to increase overall screening capacity within the service and pathway.
Work continues to ensure the current breast screening provision is improving, and once coverage has returned to pre-pandemic levels, NHS England Midlands hope to go further on ambitions to decrease inequity across all cancer screening programmes.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her policies of the data published by the Royal College of Nursing on 8 February 2024 on the proportion of general practice nursing staff that received a pay uplift for 2023-24.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
We hugely value and appreciate the vital work carried out by general practice (GP) nurses. The Government accepted the Doctors’ and Dentists’ Review Body’s recommendation on salaried GP staff pay, and increased the 2023/24 GP contract to provide funding for them to receive a 6% pay rise. We expect all practices to pass this on to staff. As self-employed contractors to the National Health Service, it is for GPs to determine employee pay.